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Cytosine methylation promotes deamination. In eukaryotes, CpG
methylation is thought to account for CpG underrepresentation.
Whether scarcity of CpGs in prokaryotic genomes is diagnostic for
methylation is not clear. Here, we report that Mycoplasms tend to
be CpG depleted and to harbor a family of constitutively expressed
or phase variable CpG-specific DNA methyltransferases. The very
CpG poorMycoplasma penetrans and its constitutively active CpG-
specific methyltransferase M.MpeI were chosen for further char-
acterization. Genome-wide sequencing of bisulfite-converted DNA
indicated that M.MpeI methylated CpG target sites both in vivo
and in vitro in a locus-nonselective manner. A crystal structure of
M.MpeI with DNA at 2.15-Å resolution showed that the substrate
base was flipped and that its place in the DNA stack was taken by
a glutamine residue. A phenylalanine residue was intercalated into
the “weak” CpG step of the nonsubstrate strand, indicating mech-
anistic similarities in the recognition of the short CpG target se-
quence by prokaryotic and eukaryotic DNA methyltransferases.
bisulfite sequencing | cytosine deamination | genome evolution |
microbiology | structural biology
Cytosine methylation is essential in many eukaryotic organ-isms (1). However, it is also mutagenic, because it drives de-
amination (2, 3). Methyl transfer promotes hydrolysis (2), and
once formed, 5-methylcytosine (5mC) deaminates twice as fast as
cytosine (3). Moreover, 5-methylation of cytosines subverts DNA
repair, because deamination of 5mC leads to thymine (a legitimate
DNA base) and not uracil (an illegitimate DNA base).
In many eukaryotes, particularly in vertebrates, cytosine meth-
ylation is predominantly found in the CpG (5′-CG-3′) sequence
context (4, 5). Consistent with methylation-driven loss, the CpG
dinucleotide is strongly underrepresented in vertebrate genomes
(6). CpG depletion is most pronounced in intergenic regions, less
so in promoter regions and introns, and least in exons, which are
subject to the strongest selective pressure (SI Appendix, Table S1).
It is not clear whether CpG loss due to methylation in mammals is
ongoing (6) or whether equilibrium between loss and restoration
of cytosines in the CpG context has been reached (7).
In prokaryotes, C5 methylation of cytosines occurs in diverse
sequence contexts. It is predominantly associated with restriction-
modification systems, targeting short palindromic or nearly pal-
indromic sites (8). Whether sequence-specific cytosine methyla-
tion in prokaryotes is correlated with depletion of target sites is
unclear. Slight underrepresentation of palindromes in the DNA
of phages and some bacteria has been reported (9, 10), but the
effects are very weak. The (near) lack of a genomic methylation
footprint could be due to transient association of restriction-
modification systems with their hosts, higher proportion of
functionally constrained DNA in prokaryotes, or the scarcity
of methylation sites (most target sequences of prokaryotic DNA
methyltransferases are at least four nucleotides long). The latter
explanation leaves open the possibility that prokaryotic cytosine
methyltransferases with dinucleotide targets could still shape
dinucleotide frequencies in host genomes. Spiroplasma monobiae
MQ1, which hosts the well-known bacterial CpG-specific DNA
methyltransferase (M.SssI), is a proprietary strain and has not had
its entire genome sequenced. The M.SssI coding gene itself is
CpG depleted (5 CpGs, 23 expected on the basis of the GC
content of the gene) (11), but some ribosomal RNA coding DNA
sequences are not.
Results
CpG Depletion in Prokaryotes. There are no reports on CpG de-
pletion in prokaryotes. Therefore, we scanned more than 3,000
bacterial genomes available from the National Center for Bio-
technology Information (NCBI) for CpG underrepresentation
(Fig. 1 and SI Appendix, Tables S2 and S3), and also as a control
for underrepresentation of other palindromic dinucleotides
(SI Appendix, Fig. S1). For each species we determined CpG
underrepresentation in the whole genome and in nonprotein
coding (“intergenic”) regions to avoid bias from codon pref-
erences. Although both overall and intergenic CpG depletion
were not smoothly distributed across the “tree of life”, a good
correlation between the two measures of CpG depletion was
found (Pearson coefficient 0.67, after removal of near duplicates
0.62). The overall very CpG poor genomes of the hyperthermophilic
Methanocaldococcus infernus (strain ME, NC_014122), intracellular
Mycoplasma penetrans (strain HF-2, NC_004432) (12), and dental
pathogen Fusobacterium nucleatum (ssp. nucleatum, NC_003454)
(13) were analyzed in more detail. The context of remaining
CpGs in the three genomes was largely dependent on the GC
content of the genome but showed only slight preferences for
flanking bases in the case of theM. penetrans genome (SI Appendix,
Fig. S2). In all three outlier genomes, only CpGs were strongly
underrepresented, but other dinucleotide frequencies did not
deviate much from expectation (SI Appendix, Fig. S3). In contrast
to the situation in eukaryotes (SI Appendix, Table S1), CpGs
were more underrepresented in coding than in noncoding
regions (Fig. 1). This observation and the dependence of CpG
underrepresentation on reading frame (SI Appendix, Table S4)
could be explained by the near absence of CpG-containing codons
in all three cases (SI Appendix, Fig. S4). Codon bias could account
for the small number of CpGs inM. infernus and F. nucleatum but
could not explain CpG underrepresentation in noncoding regions
of M. penetrans.
Candidate Constitutive and Phase Variable CpG Methyltransferases
in Prokaryotes. To correlate CpG depletion with methylation,
we used BLAST and the known amino acid sequence of M.SssI
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methyltransferase to screen for orthologs in bacterial genomes.
None are found in most bacteria (including the outlier genomes of
M. infernus and F. nucleatum). However, with search parameters
optimized for distant sequence similarity, a family of predicted C5
methyltransferases was identified. Seemingly intact methyltrans-
ferase genes were found in a few Mycoplasms, including M. pen-
etrans (mpeORF4940), which was noted for overall and intergenic
CpG depletion. In other Mycoplasms, such as Mycoplasma
pulmonis (14) or Mycoplasma crocodyli (15), frameshifts in the
genomic sequence suggested recent inactivation of a previously
functional methyltransferase gene. Interestingly, resequencing
of the M. crocodyli methyltransferase gene (mcrMORF235) did
not confirm the frameshift. The discrepancy between our and the
published sequence mapped to a dinucleotide repeat region,
strongly suggesting a polymerase slippage event during bacterial
propagation rather than a sequencing error (SI Appendix, Fig.
S5). Most but not all predicted CpG methyltransferases contain
such dinucleotide repeat tracts and are therefore probably phase
variable (SI Appendix, Table S5). We note that slipped strand
mispairing at repetitive DNA is common in bacteria (16, 17) and
has been described in Mycoplasms in the context of variations of
the repertoire of potentially immunogenic surface proteins (18).
CpG Underrepresentation and CpG Methyltransferase Expression in
Mycoplasms. M. penetrans stood out in the screens for CpG un-
derrepresentation and harbors a predicted constitutively active
CpG methyltransferase. We further noticed that on average
CpGs tend to be more underrepresented in Mycoplasms than in
other bacteria (Fig. 1). Moreover, Mycoplasms that harbor pre-
dicted constitutively active or phase variable methyltransferases
seemed to be more CpG depleted on average than Mycoplasms
without such a methyltransferase, but there were also clear
exceptions to this trend (Fig. 1 and SI Appendix, Table S5).
CpG Methylation in Mycoplasms and Other Selected Bacteria. To
check our predictions about DNA methylation, we subjected
selected bacterial genomes to bisulfite sequencing. Samples were
initially analyzed by conventional Sanger sequencing (SI Ap-
pendix, Tables S6 and S7). The relatively sparse data obtained
in this manner indicated methylation of all tested CpG sites for
M. penetrans andM. crocodyli and no CpGmethylation for the other
tested genomes (M. infernus, F. nucleatum, and also M. agalactiae
PG2, M. pulmonis, and M. mycoides ssp. capri). For further ex-
perimental studies we selected the CpG depleted M. penetrans
with a constitutively expressed DNA methyltransferase.
Bisulfite Sequencing of the M. penetrans Genome. In eukaryotes,
CpG methylation is locus-dependent. To distinguish between
locus-dependent and global CpG methylation, we bisulfite
converted M. penetrans genomic DNA. The deaminated DNA was
amplified (to overcome problems with conversion damage) and
subjected to Illumina MiSeq reversible terminator sequencing.
Because sequence coverage was very uneven (SI Appendix, Fig. S6),
the data were analyzed in two ways, giving equal weight either to
reads or to cytosines in the genome (SI Appendix, Table S8). The
latter way of analyzing the data showed that most cytosines in the
genome were either unmethylated (fraction of reads indicating
methylation ≤0.1) or highly methylated (fraction of reads indicating
methylation >0.9) (SI Appendix, Fig. S7). Both ways of analyzing
the data indicated nearly complete CpG methylation (Table 1). For
most CpGs, independent methylation information was available for
both DNA strands (SI Appendix, Fig. S8). The few sites that were
weakly or not methylated in one strand were typically well meth-
ylated in the other strand. Manual inspection of the few CpGs that
were flagged as unmethylated indicated no obvious patterns.
Therefore we attribute these sites to imperfect bisulfite conversion
and conclude that CpG methylation in M. penetrans is not locus-
specific. We also note that an unbiased analysis of methylation sites
readily identified CpG and RGCY as methyltransferase targets
(Fig. 2 and SI Appendix, Table S8). The latter is consistent with the
description of an AGCT-specific restriction-modification system
inM. penetrans but suggests that the methyltransferase has a more
relaxed specificity than currently indicated in the database (8).
Together the data show that whole genome bisulfite sequencing
can be a very useful tool to assign specificities of C5 methyl-
transferases with excellent statistical support.
In Vitro Characterization of the M. penetrans CpG-Specific
Methyltransferase. To confirm the assignment of M.MpeORF4940P
as the CpG-specific DNA methyltransferase, we overexpressed a
histidine-tagged version of the protein in Escherichia coli. The
protein was purified (SI Appendix, Fig. S9) and tested for methyl-
transferase activity in vitro (using phage λ DNA as the substrate)
(SI Appendix, Fig. S10). As predicted, the in vitro methylated
DNA was protected against the CpG methylation sensitive HpaII
(CCGG target sequence) but remained susceptible to the CpG
methylation insensitive isoschizomeric MspI endonuclease (SI
Appendix, Fig. S10). To determine the exact in vitro specificity
of M.MpeORF4940P, we used the enzyme to methylate genomic
DNA from Dcm-negative E. coli strain ER2566 and subjected this
DNA or unmethylated control DNA to bisulfite sequencing (Table
1 and SI Appendix, Table S8). Similar analysis as for the M. pene-
trans DNA showed that almost all CpG sites in M.MpeORF4940P-
treated DNA, but not control DNA, were highly methylated (Table
1 and SI Appendix, Fig. S11). Together the functional data about
M.MpeORF4940P justify renaming this protein to M.MpeI in
accordance with nomenclature guidelines (the first described
DNA methyltransferase from M. penetrans) (19).
Fig. 1. CpG underrepresentation in bacterial genomes. The degree of CpG underrepresentation (expressed as a ratio of expected and observed CpGs) was
determined for all completed genomes in NCBI (excluding nearly duplicate entries for closely related strains). Calculations were carried out either for entire
genomes or only for regions not annotated as protein coding. To exclude plasmids from the analysis only genomes above 500 kb were considered. (Right)
Mycoplasms are coded according to the predicted properties of M.MpeI orthologs in these genomes.
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Crystallization of the M.MpeI–DNA Complex. To better understand
the CpG specificity of M.MpeI and the tolerance of the related
DNA methyltransferases to sequence insertions, we aimed for a
crystal structure of the protein in complex with target DNA. The
physiological substrates of DNA methyltransferases, particu-
larly those with symmetric target sequences, are hemimethylated
(after DNA replication). Therefore, we chose a hemimethylated
oligoduplex for cocrystallization. Moreover, we placed a
5-fluorocytosine (5FC) in the position of the substrate base. We
expected that this design would interfere with the last step of
catalysis, the regeneration of the active enzyme, by preventing
the elimination of the active site cysteine (20). As a cosubstrate
we used S-adenosylmethionine (SAM). The best crystal was
obtained in a drop that contained a mixture of SAM and its
degradation product 5′-methylthioadenosine (MTA) (from scis-
sion of SAM to MTA and homoserine lactone) (21), and perhaps
also the methyltransferase coproduct S-adenosylhomocysteine
(SAH). Diffraction data extended to 2.15-Å resolution and
could be interpreted by molecular replacement using the
M.HhaI–DNA complex as a search model [Protein Data Bank
(PDB) code 2C7P] (22). The refined structure has been de-
posited in the PDB with the accession code 4DKJ (SI Appendix,
Table S9).
Overall Structure and Active Site. The M.MpeI DNA cocrystal
structure displays “classic” features of a C5-methyltransferase–
DNA complex (Figs. 3–5). The 5FC (replacing the substrate base in
the structure) is extruded from theDNA,where its place is taken by
an intercalating amino acid (Gln141). The flipped base is accom-
modated in a pocket of the methyltransferase with the Watson–
Crick edge facing Glu184. Residues Arg228 and Arg230 are also
close to the flipped base (approximately 3.0 Å) and donate one or
two hydrogen bonds to its O2 (Fig. 4A). We see no evidence for
methyl group transfer to the substrate base but also no clear methyl
group on the cofactor. The SAM binding site is probably occupied
by a mixture of SAM, MTA, and SAH. Details are difficult to dis-
cern, because the density is well defined only for the base, much
weaker for the sugar, and poor for the sulfoniumor thioether region
(Fig. 4B). The catalytic cysteine residue ofM.MpeI (Cys135) is well
positioned for nucleophilic attack on the C6 atom. However, the
Sγ–C6 distance (2.9 Å) is intermediate between a covalent bond
(1.8 Å) and noncovalent interaction (3.6 Å). A similar distance
(2.6–2.8 Å) is seen in complexes of other C5 methyltransferases
with DNA in the presence of SAH. This has been interpreted as
evidence for the formationof a partial covalent bond (23, 24), which
should be accompanied by a slight loss of substrate base planarity.
However, our resolution is insufficient to detect such detail. In
solution, neither MTA nor SAH promote irreversible covalent
bond formation, even at neutral pH (SI Appendix, Fig. S12).
Structural Basis of M.MpeI Sequence Specificity. M.MpeI not only
interacts with the flipped substrate base but also engages in
Fig. 2. Determination of C5 methyltransferase target sequences. For every possible dinucleotide (Left), trinucleotide (Center), or tetranucleotide (Right)
context, the fraction of highly methylated cytosines (>90% of reads indicating methylation) was determined. Candidate target sequences were ordered
according to the fraction of highly methylated sites, and all (Left) or the highest-scoring (Center and Right) sites were plotted. Sites that were already
identified as methylation targets by a shorter subsequence were omitted for clarity. The cytosine that was analyzed for methylation is marked by a capital
“C”; all other bases in the putative recognition sequences are given in small letters.
Table 1. High-throughput analysis of CpG methylation
Genome
M. penetrans E. coli (control) E. coli M.MpeI
First Second First Second First Second
Read-based analysis
Unconverted (methylated) CpGs 340,263 311,814 23,648 23,843 855,154 718,669
Converted (unmethylated) CpGs 7,913 7,575 2,962,773 2,616,758 57,677 49,008
Unconverted (methylated) CpGs (%) 97.7 97.6 0.8 0.9 93.7 93.6
Site-based analysis
CpGs 5,680 699,086 699,086
With methylation info 5,289 382,161 364,082
Unmethylated (%) 15 (0.3) 371,726 (97.3) 12,717 (3.5)
Intermediately methylated (%) 403 (7.6) 8,131 (2.1) 33,081 (9.1)
Highly methylated (%) 4,871 (92.1) 2,304 (0.6) 318,284 (87.4)
Methylation analysis was done by bisulfite conversion and reversible terminator sequencing. Complete statistics are provided in SI
Appendix, Table S8. In the read-based analysis, the first and second sequences from paired end sequencing were analyzed indepen-
dently. In the site-based analysis, all reads from paired end sequencing were pooled. Sites were classified as unmethylated if the
fraction of reads indicating methylation was ≤0.1 and as highly methylated if it was >0.9.








extensive interactions with the other three bases of the specifically
recognized sequence (SI Appendix, Table S10). The guanine op-
posite the flipped base (the “estranged” guanine) is recognized
by a few hydrogen bonds: Ser304 Oγ and N donate hydrogen
bonds to its O6, and Asn303 N to its N7 atom. In addition,
Gln141, which displaces the substrate C (or 5FC), accepts a bi-
furcated hydrogen bond from theN1 andN2 atoms of G (Fig. 4C).
The most striking feature of the sequence recognition by M.MpeI
is the insertion of Phe302 from the major groove side into the
5mCpG step of the nonsubstrate DNA strand. The height of
this step is almost twofold larger than usual, which results in
a substantial DNA bend or kink (Fig. 3). Despite the severe dis-
tortion, the second base pair of the recognition sequence remains
Watson–Crick hydrogen bonded. The C of this base pair donates
a hydrogen bond from its N4 atom to the carboxylate group of
Glu305. The G faces solvent with its minor groove edge and
accepts a hydrogen bond from Ala323 N to its O6 atom (Fig. 4D).
Discussion
Recognition of the CpG Target Sequence. The recognition of
a short sequence such as CpG requires multiple interactions. The
insertion of Gln141 was expected, but intercalation of Phe302
in the 5mCpG step came as a surprise. Because 5′-pyrimidine-
purine-3′ dinucleotides can be unstacked more easily than other
dinucleotides (25), the intercalation might contribute to sequence
specificity. Interestingly, a similar role of methionine intercalation
has recently been reported for the CpG sequence recognition by
ThaI restriction endonuclease (26).
M.MpeI vs. Dnmt1 and M.HhaI. It is instructive to compare the
DNA complexes of M.MpeI, Dnmt1 (the only eukaryotic DNA
methyltransferase cocrystallized with DNA) (27), and M.HhaI
(the prototypical bacterial methyltransferase, which methylates
CpG in the GCGC context) (28) (Fig. 5 and SI Appendix, Fig.
S13). The catalytic cysteine (Cys135 in M.MpeI, Cys1229 in
Dnmt1, Cys81 in M.HhaI) and glutamate (Glu184, Glu1269, and
Glu119, respectively) as well as two arginine residues that flank
the pocket for the flipped base are conserved. In all three pro-
tein–DNA complexes the flipped substrate base is displaced by
insertion of amino acid side chains from the minor (Gln141 in
M.MpeI, Met1235 in Dnmt1) or major (Lys1537 in Dnmt1,
Gln237 in M.HhaI) groove side. Nevertheless, recognition of
the CpG sequence differs between the three complexes. M.MpeI
and Dnmt1, but not M.HhaI, unstack the CpG step of the non-
substrate strand by intercalation of an amino acid side chain from
the major groove side (Phe302 in M.MpeI, Trp1512 in Dnmt1).
There are also differences in CpG recognition between the
M.MpeI and Dnmt1 cocrystal structures. In the case of M.MpeI,
the estranged guanine interacts with the intercalating Gln141.
This mode of interaction makes CpG recognition context in-
dependent. In the Dnmt1 DNA complex, the equivalent guanine
interacts with a guanine on the 5′-side of the substrate strand
CpG, at least in the crystal. However, further experiments show
that the guanine–guanine interaction in the Dnmt1 DNA
cocrystal is not important in solution (29). Thus, CpG rec-
ognition by M.MpeI and Dnmt1 might be more similar than
suggested by the comparison of the two crystal structures.
Link Between CpG Methylation and Depletion. Because the rea-
soning linking CpG methylation and depletion is universal, it
should also apply to prokaryotes. The correlative data in this
study suggest that this is the case, but other factors are also
involved and tend to obscure clear-cut correlations. Codon use
could have a particularly strong influence, because 80–90% of
bacterial genome sequences are protein coding. Whether ex-
treme codon frequencies are a consequence of DNA methyl-
ation is currently unclear. The case ofM. penetrans suggests so,
but thenM. infernus and F. nucleatum should have also harbored
CpG-specific DNA methyltransferases, which is currently specu-
lative. Interestingly, the M. penetrans CpG methyltransferase
Fig. 3. Zoom into the M.MpeI–DNA complex. The M.MpeI target sequence
(light gray) together with one flanking base pair on each side (dark gray)
and the intercalating protein residues (green) are shown. The composite
omit map is contoured at 1.5 σ (cyan). The displacement of the flipped out
substrate cytosine (here 5FC) by an amino acid side chain (Gln141) is typical
for C5 methyltransferases. The intercalation of Phe302 into the easily
unstackable 5mCpG step of the nonsubstrate strand is characteristic for
the M.MpeI–DNA complex and probably contributes to DNA recognition.
Fig. 4. M.MpeI–DNA interactions. (A) Region of the flipped 5FC base. For the Michaelis complex, a single hydrogen bond is formed between the Watson–
Crick edge of the substrate base and Glu184 at neutral pH. At acidic pH, Glu should be protonated and a second hydrogen bond may be formed. The same,
but with swapped roles of proton donor and acceptor, may happen during the reaction when the addition of the catalytic cysteine to the base converts the
N3 atom from a hydrogen bond acceptor to donor (24). (B) Alternative view of the flipped base with the substrate 5FC residue, catalytic cysteine, and co-
product SAH molecule. (C) Recognition of the “estranged” guanine base. (D) Recognition of the G:5mC pair adjacent to the flipped base. The hydrogen bonds
to the water molecules on the sugar edge of the guanine are ambiguous and are therefore not displayed. In all panels the composite omit electron density
map was contoured at 1.5 σ.
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operon contains an ORF for a predicted nuclease. The latter
might act as a restrictase in a restriction-modification system
or as a Vsr-like protein to repair methylation-induced deamination
damage. At present, we cannot exclude that CpG methylation
and depletion in some Mycoplasms represent independent adap-
tations to some external pressure either. The host immune systems
might well provide such selection. DNA with unmethylated CpGs
is very immunogenic, more so than “host like” DNA (30–32). The
pathogenic Mycoplasms, which are already less “visible” to the
host immune system than other bacteria owing to the absence
of LPS, might thus profit from both CpG methylation and de-
pletion. Whether CpG methylation contributes to Mycoplasma
pathogenicity and whether CpG depletion is caused by, rather
than correlated with, CpG methylation, remains to be addressed
in future studies.
Materials and Methods
Genomic DNA Preparation. Live cultures of F. nucleatum obtained from DSMZ
were propagated in modified peptone-yeast extract-glucose (PYG) medium
(www.dsmz.de) in Anaerobe Atmosphere Generating Bags (Oxoid) for 48 h
and then harvested by centrifugation. E. coli ER2566 was cultured in LB
broth. Genomic DNA was isolated using the Genomic Mini DNA isolation kit
(A&A Biotechnology). Genomic DNA of M. crocodyli, M. agalactiae PG2,
M. penetrans HF-2, M. pulmonis UAB CTIP, M. mycoides ssp. capri, and M.
infernus ME was obtained from D. Brown (University of Florida, Gainesville,
FL), C. Citti (INRA ENVT, Toulouse, France), Y. Sasaki (National Institute of In-
fectious Diseases, Tokyo, Japan), P. Sirand-Pugnet (Université Bordeaux, Bor-
deaux, France), F. Thiaucourt (Centre International de Recherche en Agronomie
pour le Développement, Montpellier, France), and W. Whitman (University of
Georgia, Athens, GA), respectively.
DNA Methylation in Vitro. Two micrograms of phage λ or E. coli genomic DNA
was suspended in 49 μL of 10 mM Tris·HCl (pH 8.0), 50 mM NaCl, 1 mM DTT,
and 160 μM SAM; and methylated with 1 μL of M.MpeI (1 mg/mL), 1 μL of M.
SssI (4 U/μL; NEB) for 4 h at 37 °C, or left unmethylated. Product was purified by
chloroform extraction, precipitated with LiCl/ethanol, and suspended in water.
Bisulfite Conversion and Sample Workup. Bisulfite conversion was carried out
using the EZ Methylation Kit Gold (Zymo Research). For the analysis of
methylation at randomly selected sites by Sanger sequencing, we used
MethPrimer (33) designed primers (SI Appendix, Table S6) and DreamTaq DNA
polymerase (Fermentas) for PCR amplification. For the analysis of methylation
at the genome level by reversible terminator sequencing, we amplified bi-
sulfite converted genomic DNA using the GenomePlex Whole Genome Am-
plification Kit (Sigma). The preparation of Illumina MiSeq libraries and the
actual sequencing were carried out by Genomed as a commercial service.
Analysis of Genome Sequencing Data. Paired end DNA reads were obtained
from Illumina MiSeq reversible terminator sequencing. Raw sequences in-
cluded primers or primer concatamers from the genome amplification step.
Undisclosed primer sequences were guessed with TagCleaner (34) and re-
moved with the cutadapt program (35) (requiring a remaining minimum
length of 25 bp), followed by additional cutting of 5 bp from either side.
Reads were mapped to the sequenced M. penetrans and E. coli genomes
using the Bismark program (36), which relies on bowtie (37) for efficient
alignment of reads. Because of the genome amplification step, sequence
coverage was very uneven. Hence we did not attempt to remove paired
end read redundancy and instead used in-house software to map reads to
sites. Methylation information for different sites was given equal weight
independent of the number of reads for the analysis of methylation target
sequences. For unbiased determination of methyltransferase target sequences,
these were enumerated and ordered according to the fraction of highly
methylated sites.
Fig. 5. Structural comparison of methyltransferase–
DNA complexes. M.MpeI–, Dnmt1–, and M.HhaI–DNA
complexes (PDB codes 4DKJ, 4DA4, and 3MHT) were
superposed according to the position of the 5FC
substrate base or its analog. The DNA intercalating
residues (Gln141 and Phe302 in M.MpeI; Met1235,
Trp1512, and Lys1537 in Dnmt1; Ser87 and Gln237 in
M.HhaI) are shown in stick representation. The target
CpG sequences are indicated with faint gray color and
labeled. (Left) Overall structure of the three enzymes
together with bound DNA and coproduct S-adeno-
sylhomocysteine. (Right) The structures are 90° ro-
tated and zoomed on the target CpG sequences. A
single flanking G nucleotide in Dnmt1 complex that
forms a nonstandard base pair with the specifically
recognized G is indicated in black.








Cloning. The genomic DNA ofM. penetrans strain HF-2 (12) was obtained from
Yuko Sasaki (National Institute of Infectious Diseases, Tokyo, Japan). The gene
encoding M.MpeI was amplified by PCR and cloned into the NcoI and XhoI
sites of pET-28a (Novagen, KmR), yielding a full-length ORF with a C-terminal
LEHHHHHH tag.M. penetrans has a nonstandard genetic code, therefore four
TGAs in the cloned sequence were mutated to TGG with Pfu Plus! DNA
polymerase (Eurx) using conventional point mutagenesis. The obtained pET-
28a::MMpe construct coded for a protein with the unintended mutations
Q68R and K71R that might result from the natural variation between strains.
An S295P mutation was introduced deliberately to prevent proteolysis.
Protein Expression and Purification. E. coli ER 2566 strain (NEB) was trans-
formed with pET-28a::MMpe and grown overnight on LB-agar supplemented
with 1% glucose. Selected colonies were used to inoculate a preculture grown in
LB medium with 0.1% glucose at 37 °C. After 8 h, 20 mL of the preculture was
added to 1 L of Terrific broth supplemented with 1 mMMgCl2, 0.05% glucose,
and 0.2% lactose. The expression culture was grown for 18 h at 28 °C and
harvested by centrifugation (20 min; 4,000 × g). The pellet was suspended in
20 mL of disruption buffer [20 mM Tris·HCl (pH 7.5), 100 mM NaCl, 10 mg/mL
lysozyme, 1 mg/mL DNase I, and protease inhibitor mixture from Sigma], in-
cubated for 15 min at 37 °C and disrupted by sonication. The cell lysate was
cleared by ultracentrifugation (30 min; 190,000 × g) and precipitated with
an equal volume of a saturated (NH4)2SO4 solution. After 1 h incubation on
ice the salted-out proteins were removed by centrifugation (30 min; 10,000
× g). The soluble fraction was titrated to pH 8.0 using 1 M Tris·HCl (pH 8.5)
and loaded onto a Nickel-NTA column (Qiagen) preequilibrated with 20 mM
Tris·HCl (pH 7.5), 300 mM NaCl, 20 mM imidazole, and 0.01% nonaethylene
glycol monododecyl ether. The column was extensively washed with the
same buffer and then with 20 mM Tris·HCl (pH 7.5), 300 mM NaCl, 40 mM
imidazole, and 0.01% nonaethylene glycol monododecyl ether. M.MpeI
was eluted with 20 mM Tris·HCl (pH 7.5), 300 mM NaCl, and 100 mM im-
idazole, and subjected to gel filtration on a HiLoad 16/60 Superdex 75 col-
umn (GE Healthcare) in 10 mM Tris·HCl (pH 7.5), 50 mM NaCl, and 1 mM DTT.
Crystal Structure Determination. M.MpeI (5 mg/mL) in 10 mM NaOH·Hepes
(pH 8), 120 mM NaCl, 5% glycerol (wt/vol), and dsDNA (5′-GTTCAG5mCG-
CATGTG-3′ and 5′-CCACATG5FCGCTGAA-3′) in 10 mM Tris·HCl (pH 8.0) and
SAM were mixed 1:1:1. Crystals were obtained from 10% PEG 3350, 150 mM
NaCl, and 50 mM sodium citrate (final pH, 5.6) and cryoprotected with
glycerol (25% vol/vol final concentration). Diffraction data to 2.15 Å were
collected at 100 K and 0.9795 Å (IO2 beamline, Diamond Light Source) and
processed with MOSFLM and SCALA (38). DIBER (39) confirmed the presence
of protein and DNA in the crystals. The structure was solved using MOLREP
(38) and the CHAINSAW (38) modified M.HhaI model (PDB code 2C7P). ARP/
wARP (40) was used for model building, COOT (38), REFMAC (38), and CNS
(41) for refinement. Of the final model, 97.9% protein residues were in fa-
vored Ramachandran plot regions [MolProbity (42)]. SI Appendix, Table S9
summarizes data collection and refinement statistics. Atomic coordinates
and structure factors for the M.MpeI-DNA complex structure have been
deposited in the PDB under accession code 4DKJ.
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